DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Myriad Genetics, Inc. (MYGN)
« Back to company indexMYGN Chatter Timeline
Stock Ticker for MYGN
Most Active Tweeters for MYGN
| User | Tweets |
|---|---|
| @bulletin_en | 6 |
| @AmericanBanking | 6 |
| @OlympiaReport | 5 |
| @whatsonthorold2 | 5 |
| @mmahotstuff1 | 4 |
Recent Tweets for MYGN
 |
@KTJohansen RT @myriadgenetics: Myriad to present 18 studies at the 2019 Annual Clinical Genetics Meeting. Learn more: https://t.co/L7QFRLNop9 $MYGN @M… March 21st 2019, 11:03pm |
 |
@FlyOnTheWallHQ RT @FlyOnTheWallHQ: A Man For All Seasons_MYRIAD GENETICS $MYGN CEO To Announce An Open Market Share Buy Back Program To Begin As Early As… March 21st 2019, 8:03am |
 |
@ProTradersNews $MYGN: Myriad to Present 18 Studies at the 2019 Annual Clinical Genetics …: https://t.co/DNwgBwbxjI March 21st 2019, 7:03am |
 |
@StockTexts $MYGN Myriad to Present 18 Studies at the 2019 Annual Clinical Genetics Meeting Nasdaq:MYGN https://t.co/ELtRSF6m3l March 21st 2019, 7:03am |
 |
@AmericanBanking Analysts Anticipate Myriad Genetics, Inc. $MYGN Will Post Quarterly Sales of $218.38 Million https://t.co/cBkbf47jLw #stocks March 21st 2019, 3:03am |
 |
@dakotafinancial Analysts Anticipate Myriad Genetics, Inc. $MYGN Will Post Quarterly Sales of $218.38 Million https://t.co/2u7rESnJ3I March 21st 2019, 3:03am |
 |
@macondailynews $218.38 Million in Sales Expected for Myriad Genetics, Inc. $MYGN This Quarter https://t.co/8cKr91qQhn March 21st 2019, 3:03am |
|
@FlyOnTheWallHQ A Man For All Seasons_MYRIAD GENETICS $MYGN CEO To Announce An Open Market Share Buy Back Program To Begin As Early… https://t.co/TDEbTu7kCi March 20th 2019, 7:03pm |
 |
@TranscriptDaily Myriad Genetics, Inc. $MYGN Receives Average Rating of “Hold” from Brokerages https://t.co/gsiPoZyuP0 March 20th 2019, 3:03pm |
 |
@bulletin_en Myriad Genetics Inc $MYGN Big Money Sentiment Index Crashed in 2018 Q4 to 1.23 https://t.co/zIn4FCndeU March 20th 2019, 11:03am |
 |
@StockTweetsHQ RT @StockTweetsHQ: A Man For All Seasons_MYRIAD GENETICS $MYGN CEO To Announce An Open Market Share Buy Back Program To Begin As Early As N… March 20th 2019, 9:03am |
|
@StockTweetsHQ A Man For All Seasons_MYRIAD GENETICS $MYGN CEO To Announce An Open Market Share Buy Back Program To Begin As Early… https://t.co/K8KJZP8L8K March 19th 2019, 8:03pm |
 |
@mmahotstuff1 How Analysts Feel About Myriad Genetics, Inc. $MYGN? https://t.co/PGliulYdUI March 19th 2019, 1:03pm |
|
@AmericanBanking Brokerages Expect Myriad Genetics, Inc. $MYGN Will Announce Earnings of $0.44 Per Share https://t.co/Nv7eew7rmj #stocks March 19th 2019, 9:03am |
 |
@OlympiaReport Brokerages Expect Myriad Genetics, Inc. $MYGN Will Announce Earnings of $0.44 Per Share https://t.co/rNbPsmOF2P March 19th 2019, 9:03am |
|
@bulletin_en Myriad Genetics Inc $MYGN Sellers Rose Their Shorts By 3.27% https://t.co/mnBVZp9LO8 March 19th 2019, 9:03am |
 |
@FinZTribune Myriad Genetics Inc $MYGN Shorts Increased By 3.27% https://t.co/SdrPpKZeCS March 19th 2019, 8:03am |
|
@macondailynews Analysts Set Myriad Genetics, Inc. $MYGN Price Target at $41.41 https://t.co/Y3msAwazjy March 18th 2019, 9:03am |
 |
@TheMarketsDaily Brokerages Set Myriad Genetics, Inc. $MYGN Price Target at $41.41 https://t.co/4h7A8BCefO March 18th 2019, 9:03am |
 |
@thefinreviewer As Myriad Genetics $MYGN Share Price Declined, Mesirow Financial Investment Management Us Value Equity Trimmed Its… https://t.co/WvjWm0KbbU March 17th 2019, 2:03pm |
 |
@ArizetSignals 17 MAR 2019 - Week's Top Gainers $MYGN @ $33.65 1-Week Return: 15.36% Combined Score: -96.0 Sentiment: BEARISH Conf… https://t.co/sguSwvZMzZ March 17th 2019, 1:03pm |
|
@thefinreviewer Myriad Genetics $MYGN Holder Tieton Capital Management Lowered Its Holding; Willingdon Wealth Management Decreased… https://t.co/OU0BgaJbz7 March 17th 2019, 12:03pm |
 |
@registrarjourn Myriad Genetics, Inc. $MYGN Receives $41.41 Average PT from Brokerages https://t.co/r4gMHW7LKU March 16th 2019, 7:03pm |
 |
@EnterpriseLeade Myriad Genetics, Inc. $MYGN Receives $41.41 Average PT from Brokerages https://t.co/n7A2JXEXV0 March 16th 2019, 7:03pm |
 |
@dispatchtribune Myriad Genetics, Inc. $MYGN Receives $41.41 Consensus Price Target from Analysts https://t.co/MAYx2fmk4v March 16th 2019, 7:03pm |
|
@dispatchtribune Myriad Genetics $MYGN Given “Strong-Buy” Rating at Needham & Company LLC https://t.co/WrdUltiY56 March 16th 2019, 6:03pm |
|
@OlympiaReport Myriad Genetics $MYGN Given “Strong-Buy” Rating at Needham & Company LLC https://t.co/dpNu4WVZWP March 16th 2019, 8:03am |
|
@mmahotstuff1 How Analysts Feel About Myriad Genetics, Inc. $MYGN? https://t.co/oUyADCUFSW March 16th 2019, 7:03am |
 |
@whatsonthorold2 Can analysts adopt a bullish outlook for Myriad Genetics, Inc. $MYGN? https://t.co/iDqtWd9ZRa March 16th 2019, 7:03am |
 |
@reurope_stock How Many Myriad Genetics, Inc. $MYGN's Analysts Are Bearish? https://t.co/s2XKq46KWY March 16th 2019, 7:03am |
 |
@WatchlistN Myriad Genetics $MYGN Earns Strong-Buy Rating from Needham & Company LLC https://t.co/CgAHs8nmtQ March 15th 2019, 1:03pm |
|
@OlympiaReport Myriad Genetics, Inc. $MYGN Insider Sells $61,225.00 in Stock https://t.co/8zDsK0BRLl March 15th 2019, 12:03pm |
|
@dispatchtribune Myriad Genetics, Inc. $MYGN Insider Sells $61,225.00 in Stock https://t.co/YUbh6Yw9QG March 15th 2019, 12:03pm |
|
@thefinreviewer Arizona State Retirement System Raised Myriad Genetics $MYGN Stake; EQUINOX GOLD NEW $EQXFF SI Increased By 18.04% https://t.co/QNwFrikodF March 15th 2019, 8:03am |
 |
@classicoptions $MYGN classic bullish inverse head & shoulder breakout https://t.co/xzb1QlNKgz March 15th 2019, 3:03am |
|
@StreetCitizen RT @the_chart_life: $MYGN Myriad Genetics ...Big base. https://t.co/Sq3X6ibWai March 14th 2019, 9:03pm |
 |
@the_chart_life $MYGN Myriad Genetics ...Big base. https://t.co/Sq3X6ibWai March 14th 2019, 8:03pm |
 |
@MaisaCorp $MYGN Palmetto GBA MolDx, a Medicare administrative contractor, issued a final local coverage determination for th… https://t.co/mNRtLt89MM March 14th 2019, 4:03pm |
 |
@bibeypost_stock Today Piper Jaffray Reiterates a Buy Rating on Myriad Genetics $MYGN and a $47 Target Price https://t.co/GuPetYMcIT March 14th 2019, 4:03pm |
|
@bulletin_en Disciplined Growth Investors Has Lowered Myriad Genetics Com $MYGN Holding; D-C-Capital Advisors LTD Lowered Its Ca… https://t.co/RFa1sp6MCz March 14th 2019, 3:03pm |
|
@bulletin_en Myriad Genetics Inc $MYGN Stock Sentiment Dropped to 1.23 https://t.co/SoH7zPJ59p March 14th 2019, 2:03pm |
 |
@ConsumerFeed Ralph L. Mcdade Sells 1,975 Shares of Myriad Genetics, Inc. $MYGN Stock https://t.co/SvpSPRzT1x March 14th 2019, 1:03pm |
|
@whatsonthorold2 Myriad Genetics, Inc. $MYGN Has Another Very Strong Trading Session https://t.co/MowgShSz2e March 14th 2019, 12:03pm |
 |
@jarrodmax RT @myriadgenetics: BREAKING NEWS! Myriad’s myPath® Melanoma test receives Medicare coverage. Learn more: https://t.co/tPrzJUGhLd $MYGN #Me… March 14th 2019, 10:03am |
 |
@marketexclusive $MYGN MYRIAD GENETICS, INC. (NASDAQ:MYGN) Files An 8-K Regulation FD Disclosure https://t.co/MnoCMgrmtT March 14th 2019, 9:03am |
|
@StockTexts $MYGN Myriad Genetics, Inc. SEC Filing: Form 8-K https://t.co/B0MEZifNGh March 14th 2019, 9:03am |
|
@marketexclusive $MYGN MYRIAD GENETICS, INC. (NASDAQ:MYGN) Files An 8-K Regulation FD Disclosure https://t.co/j4knxmCeTV March 14th 2019, 9:03am |
 |
@myriadgenetics BREAKING NEWS! Myriad’s myPath® Melanoma test receives Medicare coverage. Learn more: https://t.co/tPrzJUGhLd $MYGN… https://t.co/2wK98QTsRR March 14th 2019, 9:03am |
|
@StockTexts $MYGN Myriad’s myPath® Melanoma Test Receives Medicare Coverage Nasdaq:MYGN https://t.co/DU0WtiKCD3 March 14th 2019, 8:03am |
 |
@gtlackey $MYGN 1st higher low in a bit & held the RSI bull range as well. back at top of range, through it has room to the g… https://t.co/2jLujlN9JQ March 14th 2019, 6:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.